Local view for "http://purl.org/linkedpolitics/eu/plenary/2001-03-15-Speech-4-037"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20010315.4.4-037"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
"Mr President, the rapporteur is aware that the Green Group has criticised this report as unbalanced and it indeed is unashamedly pro-biotech industry, doubtless because of the explicit involvement of Glaxo Wellcome – or whatever they are now called – in preparatory meetings.
However, the report in no way affects the legislative programme, which is addressing such issues as traceability, labelling and liability. The report has not dealt with serious concerns such as ethics in biotechnology, public health, consumers' concerns regarding food, and indeed the effects on the environment.
However, the most extraordinary thing in this report is the reference to the market and the creation and availability of new financial resources and the rationality of European stock markets. I thought Mr Purvis clearly understood that stock markets are beyond the control even of a powerful Commissioner like Mr Liikanen and I urge him to ignore this extraordinary interventionist proposal."@en1
|
| lpv:spokenAs | |
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples